Discontinuation report BACLOFEN INTRATHECAL
| Report ID | 252798 |
| Drug Identification Number | 02485494 |
| Brand name | BACLOFEN INTRATHECAL |
| Common or Proper name | Baclofen intrathecal 0.05 mg/mL |
| Company Name | AVIR PHARMA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | BACLOFEN |
| Strength(s) | 0.05MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRATHECAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1ml |
| ATC code | M03BX |
| ATC description | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-03-03 |
| Actual discontinuation date | 2025-03-03 |
| Remaining supply date | 2025-03-03 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | This discontinuation only affects the 0.05 mg/mL strength. The other available strengths of baclofen intrathecal (0.5 mg/mL and 2 mg/mL) remain unchanged |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOULEVARD INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-03-17 | French | Compare |
| v3 | 2025-03-17 | English | Compare |
| v2 | 2025-03-17 | French | Compare |
| v1 | 2025-03-17 | English | Compare |
Showing 1 to 4 of 4